Eli Lilly and Company

CONSULTOR TÉCNICO SR - IMUNOLOGIA

Brazil

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a relevant higher education degree, such as a Bachelor’s degree, and preferably a postgraduate degree in Immunology or a related scientific field. Prior experience as a Technical Consultant, particularly within the pharmaceutical or biotechnology industry, is highly desirable. Strong knowledge of immunology and specific disease areas (Psoriasis, Arthritis, etc.) is required, along with proficiency in English at the intermediate level. Familiarity with CRM systems (VEEVA) and Microsoft Office Suite is also expected.

Responsibilities

The Consultant Técnico Imunologia will provide technical and commercial consulting services to clients, including physicians and infusion clinics, to ensure access to Lilly’s immunobiological and targeted therapies. This involves implementing marketing strategies to maximize product demand and improve patient quality of life. Key responsibilities include planning and executing technical and commercial strategies, interacting with clients, maintaining medical knowledge, collaborating with cross-functional teams, analyzing and managing accounts, and promoting a culture of safety and diversity. The role also requires travel up to 60% of the time and adherence to Lilly’s principles and values.

Skills

MedicalConsulting
MarketAccess
CustomerInteraction
StrategicPlanning
ProductKnowledge
PromotionStrategies

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI